Shared Decision Making: Understanding Your Immunotherapy Options When You Have Kidney Cancer
KidneyCAN's April 2022 Town Hall event focused on immunotherapy options for patients with #kidneycancer. Our panel of expert oncologists included Dr. Naomi Haas from Penn Medicine, Dr. Hans Hammers from UTSW, and Dr. Monty Pal from City of Hope, who discussed how they share the immunotherapy treatment decision-making process with their patients.
Following their discussions, the doctors took questions from patients all over the world. You can watch the full event here. To get notified when KidneyCAN has additional patient education or advocacy events, be sure to sign up for our newsletter at www.kidneycan.org.
—————————————————————————
KidneyCAN works to accelerate cures for kidney cancer by providing patient support and education, encouraging enrollment in clinical trials, advocating for research funding from Congress, and sponsoring collaborative efforts between researchers and medical communities.
To learn more about KidneyCAN: https://kidneycan.org
Support our work: https://kidneycan.org/donate
-
Category
No comments found